Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software
暂无分享,去创建一个
H. Saint-Jalmes | Y. Gandon | E. Bannier | C. Aubé | P. Otal | B. Turlin | J. Boursier | E. Frampas | J. Chaigneau | E. Bardou-Jacquet | A. Boulic | H. Chau | T. Orcel | A. Leguen
[1] Jean A. Tkach,et al. Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study. , 2021, Radiology.
[2] Youming Li,et al. A meta‐analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease , 2020, European journal of clinical investigation.
[3] B. Magnin,et al. Quantification of steatosis in alcoholic and nonalcoholic fatty liver disease: Evaluation of four MR techniques versus biopsy. , 2019, European journal of radiology.
[4] Y. Xin,et al. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis , 2019, European Radiology.
[5] G. Hamilton,et al. Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis , 2019, European Radiology.
[6] Seamus O'Reilly,et al. Use of Liver Imaging and Biopsy in Clinical Practice. , 2017, The New England journal of medicine.
[7] N. Obuchowski,et al. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. , 2017, Radiology.
[8] P. Lundberg,et al. Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis. , 2017, Gastroenterology.
[9] M. House,et al. Stereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRI , 2016, PloS one.
[10] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[11] Alexandra N. Schlein,et al. Accuracy and the effect of possible subject‐based confounders of magnitude‐based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference , 2016, Journal of magnetic resonance imaging : JMRI.
[12] A. Gamst,et al. Accuracy of multiecho magnitude‐based MRI (M‐MRI) for estimation of hepatic proton density fat fraction (PDFF) in children , 2015, Journal of magnetic resonance imaging : JMRI.
[13] S. Galimberti,et al. Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia , 2015, Scandinavian journal of gastroenterology.
[14] A. Gamst,et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. , 2015, Radiology.
[15] F. F. Paiva,et al. Is MR Spectroscopy Really the Best MR-Based Method for the Evaluation of Fatty Liver in Diabetic Patients in Clinical Practice? , 2014, PloS one.
[16] B. Choi,et al. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. , 2014, Radiology.
[17] R. Idilman,et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. , 2013, Radiology.
[18] Nele Friedrich,et al. Noninvasive Quantification of Hepatic Fat Content Using Three-Echo Dixon Magnetic Resonance Imaging With Correction for T2* Relaxation Effects , 2011, Investigative radiology.
[19] S. Bertrais,et al. Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD , 2011, European journal of gastroenterology & hepatology.
[20] C. Sirlin,et al. In vivo characterization of the liver fat 1H MR spectrum , 2011, NMR in biomedicine.
[21] John Hart,et al. Comparing morphometric, biochemical, and visual measurements of macrovesicular steatosis of liver. , 2011, Human pathology.
[22] S. Horgan,et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. , 2011, Radiology.
[23] Scott B Reeder,et al. Quantification of liver fat with magnetic resonance imaging. , 2010, Magnetic resonance imaging clinics of North America.
[24] C. Cavaro-Ménard,et al. Noninvasive liver steatosis quantification using MRI techniques combined with blood markers , 2010, European journal of gastroenterology & hepatology.
[25] R. Levine,et al. Digital Quantification Is More Precise than Traditional Semiquantitation of Hepatic Steatosis: Correlation with Fibrosis in 220 Treatment-Naïve Patients with Chronic Hepatitis C , 2010, Digestive Diseases and Sciences.
[26] G. Bedogni,et al. Epidemiology of Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.
[27] K. Washington,et al. Assessment of Hepatic Steatosis by Expert Pathologists: The End of a Gold Standard , 2009, Annals of surgery.
[28] S. Reeder,et al. Quantification of hepatic steatosis with MRI: The effects of accurate fat spectral modeling , 2009, Journal of magnetic resonance imaging : JMRI.
[29] A. Gamst,et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. , 2009, Radiology.
[30] R. Nelson,et al. Liver biopsy , 2009, Hepatology.
[31] S. Reeder,et al. Multiecho water‐fat separation and simultaneous R 2* estimation with multifrequency fat spectrum modeling , 2008, Magnetic resonance in medicine.
[32] H. Hussain,et al. Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. , 2005, Radiology.
[33] Lennart Bodin,et al. Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting , 2005, Modern Pathology.
[34] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[35] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[36] C. Tiribelli,et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis , 1995, Journal of magnetic resonance imaging : JMRI.
[37] C. Sirlin,et al. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib. , 2019, Journal of hepatology.
[38] J. Stoker,et al. UvA-DARE ( Digital Academic Repository ) Applications of magnetic resonance spectroscopy for noninvasive assessment of hepatic steatosis , 2011 .
[39] J. Bruzzi,et al. Liver biopsy. , 2001, The New England journal of medicine.